Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium)
- 1 September 1978
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 75 (3), 479-485
- https://doi.org/10.1016/0016-5085(78)90854-5
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HCl in healthy subjects: Single-dose studies by the intravenous, intramuscular, and oral routesJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Increased sensitivity to nitrazepam in old age.BMJ, 1977
- Intravenous administration of diazepam in patients with chronic liver disease.Gut, 1976
- Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the dataJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Pharmacokinetics in the ElderlyClinical Pharmacokinetics, 1976
- Pharmacokinetics in the aged: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Radioimmunoassay of Chlordiazepoxide in PlasmaJournal of Pharmaceutical Sciences, 1975
- Biological Half-Life of Chlordiazepoxide and Its Metabolite, Demoxepam, in ManJournal of Pharmaceutical Sciences, 1971
- Shortcomings in Pharmacokinetic Analysis by Conceiving the Body to Exhibit Properties of a Single CompartmentJournal of Pharmaceutical Sciences, 1968
- Metabolic N-Demethylation of ChlordiazepoxideJournal of Pharmaceutical Sciences, 1966